AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2018
Jun 7, 2018
32566_dirs_2018-06-07_2299ec91-ff66-4573-8a3c-a6a8b4446adc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2018-06-05
Reporting Person: GILBERT WALTER PHD (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-06-05 | Common Stock | M | 28811 | $24.39 | Acquired | 56054 | Direct |
| 2018-06-05 | Common Stock | S | 28811 | $39.6816 | Disposed | 27243 | Direct |
| 2018-06-06 | Common Stock | M | 1189 | $24.39 | Acquired | 28432 | Direct |
| 2018-06-06 | Common Stock | S | 1189 | $39.8 | Disposed | 27243 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-06-05 | Non-Qualified Stock Option (right to buy) | $24.39 | M | 28811 | Disposed | 2018-11-13 | Common Stock (28811) | Direct |
| 2018-06-06 | Non-Qualified Stock Option (right to buy) | $24.39 | M | 1189 | Disposed | 2018-11-13 | Common Stock (1189) | Direct |
More from MYRIAD GENETICS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 5
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 2